FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Pierce

Research Profile

Anatomy

Chemicals & Drugs

Disorders

Melanoma

Physiology

Procedures

Genes & Molecular Sequences

Alleles

Concepts & Ideas

Sequence Homology, Amino Acid

Co-author Network

Publications

TOP 3
Lee W Thompson; Courtney F Garbee; Sarah Hibbitts; Laurence H Brinckerhoff; Richard A Pierce; Kimberly A Chianese-Bullock; Donna H Deacon; Victor H Engelhard; Craig L Slingluff
Competition among peptides in melanoma vaccines for binding to MHC molecules.
Lee W Thompson; Kevin T Hogan; Jennifer A Caldwell; Richard A Pierce; Ronald Hendrickson; Donna H Deacon; Robert E Settlage; Laurence H Brinckerhoff; Victor H Engelhard; Jeffrey Shabanowitz; Donald F Hunt; Craig L Slingluff
Preventing the spontaneous modification of an HLA-A2-restricted peptide at an N-terminal glutamine or an internal cysteine residue enhances peptide antigenicity.
Eric Spierings; Anthony Brickner; Jennifer A Caldwell; Suzanne Zegveld; Nia Tatsis; Els Blokland; Jos Pool; Richard A Pierce; Sahana Mollah; Jeffrey Shabanowitz; Laurence C Eisenlohr; Peter van Veelen; Ferry Ossendorp; Donald F Hunt; Els Goulmy; Victor H Engelhard
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Pierce (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Lee W Thompson; Courtney F Garbee; Sarah Hibbitts; Laurence H Brinckerhoff; Richard A Pierce; Kimberly A Chianese-Bullock; Donna H Deacon; Victor H Engelhard; Craig L Slingluff
Competition among peptides in melanoma vaccines for binding to MHC molecules.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(6):425-31.
2004: Lee W Thompson; Kevin T Hogan; Jennifer A Caldwell; Richard A Pierce; Ronald Hendrickson; Donna H Deacon; Robert E Settlage; Laurence H Brinckerhoff; Victor H Engelhard; Jeffrey Shabanowitz; Donald F Hunt; Craig L Slingluff
Preventing the spontaneous modification of an HLA-A2-restricted peptide at an N-terminal glutamine or an internal cysteine residue enhances peptide antigenicity.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(3):177-83.
2003: Eric Spierings; Anthony Brickner; Jennifer A Caldwell; Suzanne Zegveld; Nia Tatsis; Els Blokland; Jos Pool; Richard A Pierce; Sahana Mollah; Jeffrey Shabanowitz; Laurence C Eisenlohr; Peter van Veelen; Ferry Ossendorp; Donald F Hunt; Els Goulmy; Victor H Engelhard
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein.
Blood 2003;102(2):621-9.
2001: Richard A Pierce; E D Field; Tuna Mutis; Tatiana N Golovina; Chris Von Kap-Herr; Martina Wilke; Jos Pool; Jeffrey Shabanowitz; Mark J Pettenati; Laurence C Eisenlohr; Donald F Hunt; Els Goulmy; Victor H Engelhard
The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(6):3223-30.
2000: Teresa A Colella; Timothy N J Bullock; L B Russell; David W Mullins; W W Overwijk; Chance John Luckey; Richard A Pierce; N P Restifo; Victor H Engelhard
Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy.
The Journal of experimental medicine 2000;191(7):1221-32.
1999: Richard A Pierce; E D Field; Joke M M den Haan; Jennifer A Caldwell; Forest M White; Jarrod A Marto; W Wang; L M Frost; Els Blokland; C Reinhardus; Jeffrey Shabanowitz; Donald F Hunt; Els Goulmy; Victor H Engelhard
Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(12):6360-4.
1999: Laurence H Brinckerhoff; V V Kalashnikov; Lee W Thompson; Galina V Yamshchikov; Richard A Pierce; Holly Galavotti; Victor H Engelhard; Craig L Slingluff
Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: implications for peptide vaccines.
International journal of cancer. Journal international du cancer 1999;83(3):326-34.
1997: W Wang; PH Gulden; Richard A Pierce; Jeffrey Shabanowitz; S T Man; Donald F Hunt; Victor H Engelhard; J A Shabanowitz
A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8+ cytotoxic T cell with apparent high affinity.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(12):5797-804.
1996: R P Sanders; N Craig Goodman; L R Amiss; Richard A Pierce; MM Moore; G Marx; Raymond F Morgan; William D Spotnitz
Effect of fibrinogen and thrombin concentrations on mastectomy seroma prevention.
The Journal of surgical research 1996;61(1):65-70.